Integrating minimal residual disease into postoperative treatment selection for head and neck cancer. Okuyama K, Yanamoto S. Oral Oncol 2026;182:108121.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okuyama K, Yanamoto S. Integrating minimal residual disease into postoperative treatment selection for head and neck cancer. Oral Oncol 2026;182:108121.
PMID: 42696860